Literature DB >> 7958483

Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.

B Moss1.   

Abstract

Vaccinia virus, effectively used for immunization against smallpox, now serves as a recombinant vector for the development of vaccines against other infectious agents and cancer. Recent advances have led to increased gene expression, enhanced immunogenicity, and greater safety. Both replicating and host-restricted non-replicating vectors are available.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7958483

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN： 0301-5149


  3 in total

1.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases.

Authors:  M F Gnant; M Puhlmann; D L Bartlett; H R Alexander
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

3.  Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.

Authors:  Xiugen Zhang; Farah Cassis-Ghavami; Mike Eller; Jeff Currier; Bonnie M Slike; Xuemin Chen; James Tartaglia; Mary Marovich; Paul Spearman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.